Thao Doan

Thao T. Doan, MD

Senior Medical Director, Medical Safety Evaluation, Pharmacovigilance and Patient Safety, AbbVie

SELECTED PUBLICATIONS

• Doan T. Patterson R, Greenberger PA. Cough Variant Asthma: Usefulness of a Diagnostic-Therapeutic Trial with Prednisone. Annals of Allergy, 1992: 69:505-9.
• Doan T, Grrenberger PA, Pelzer H. Sinusitis. Allergy Proceedings, 1993; 14:117-8.
• Doan T, Zeiss CR. Skin Testing in Allergy. Allergy Proceeding, 1993.
• Doan T, Greenberger PA. Nearly Fatal Episodes of Hypotension, Flushing, and Dyspnea in a 47-year-old woman. Annals of Allergy, 1993; 70:439-444.
• Patterson R, Miller M, Kaplan M Doan T, et al, Effectiveness of Early Therapy with Corticosteroids in Stevens-Johnson syndrome: Experience with 41 Cases and a Hypothesis Regarding Pathogenesis. Annal of Allergy, 1994: 73:27-34.
• Doan T, Grammer LC, Yarnold PR, Greenberger PA, Patterson R. An intervention Program to Reduce the Hospitalization Cost of Asthma Patients Requiring Intubation. Annals of Allergy, Asthma and Immunology, 1996: 76:513-518.
• Nelson HS, Grossman J, Dube L. Doan T et al. The effect of ABT-761, A novel 5-lipoxygenase Inhibitor, in patients with moderate asthma. Chest, 1996:110:4, 33S.
• Doan, T, Wang, Q, Griffin, JS, Lukasik, NL, O'Dea, RF and Pan WJ: Comparative pharmacokinetics and pharmacodynamics of lasoprazole oral capsule and suspension in healtjhy subjects. Amer J. Health System Pharmacy 58:1512-1519, 2001.
• Katz DA, Carr R, Grimm DR, Xiong H, Holley-Shanks R, Mueller T, Leake B, Wang Q, Han L, Edeki T, Sahelijo L, Doan T, Allen A, Spear BB, Kim RB. OATP1B1 actively classified by SLCO1B1 genotype influences atrasentan pharmacokinetics 20065. Clinical Pharmacology & Therapeutics.
• Xiong H, Carr R, Locke C, Katz D, Achari R, Doan T, Wang P, Jankowski J, Sleep D, Dual Effects of Rifampin on the Pharmacokinetics of Atrasentan. 20017 Clinical Pharmacology & Therapeutics.